Prognostic value of pneumonitis after durvalumab in locally-advanced non-small cell lung cancer

被引：0
|
作者：
Nishimura, Ari [1 ]
Ono, Akira [1 ]
Wakuda, Kazushige [1 ]
Kawabata, Takanori [2 ]
Yabe, Michitoshi [1 ]
Miyawaki, Taichi [1 ]
Miyawaki, Eriko [1 ]
Kodama, Hiroaki [1 ]
Nishioka, Naoya [1 ]
Mamesaya, Nobuaki [1 ]
Kobayashi, Haruki [1 ]
Omori, Shota [1 ]
Kenmostu, Hirotsugu [1 ]
Naito, Tateaki [1 ]
Murakami, Haruyuki [1 ]
Harada, Hideyuki [3 ]
Takahashi, Toshiaki [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Clin Res Promot Unit, Clin Res Ctr, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Div Radiat Therapy, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO21-1
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [1] Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
    Hassanzadeh, Comron
    Sita, Timothy
    Savoor, Rohan
    Samson, Pamela P.
    Bradley, Jeffrey
    Gentile, Michelle
    Roach, Michael
    Mohindra, Nisha
    Waqar, Saiama
    Kruser, Timothy J.
    Robinson, Clifford
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 6690 - 6700
  • [2] Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer
    Ari Nishimura
    Akira Ono
    Kazushige Wakuda
    Takanori Kawabata
    Michitoshi Yabe
    Taichi Miyawaki
    Eriko Miyawaki
    Hiroaki Kodama
    Naoya Nishioka
    Nobuaki Mamesaya
    Haruki Kobayashi
    Shota Omori
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Hideyuki Harada
    Toshiaki Takahashi
    [J]. Investigational New Drugs, 2022, 40 : 464 - 464
  • [3] Early administration of durvalumab after chemoradiotherapy increased risk of pneumonitis in patients with locally advanced non-small cell lung cancer
    Harada, Daijiro
    Shimonishi, Atsushi
    Saeki, Kazuhiko
    Ninomiya, Takashi
    Kanzaki, Hiromitsu
    Nagasaki, Kei
    Ogura, China
    Tsutsui, Yoko
    Kojin, Kazuhiro
    Hamamoto, Yasushi
    Kozuki, Toshiyuki
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (02) : E111 - E117
  • [4] A Prognostic Score for Patients Receiving Multimodal Treatment for Locally-Advanced Non-Small Cell Lung Cancer
    Taugner, J.
    Roengvoraphoj, O.
    Kasmann, L.
    Petruknov, O.
    Gennen, K.
    Reem, A.
    Dantes, M.
    Eze, C.
    Belka, C.
    Manapov, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S859 - S859
  • [5] Exploring Associations between Immune Parameters and Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer after Chemoradiation and Durvalumab
    Thor, M.
    Shaverdian, N.
    Shepherd, A. F.
    Offin, M.
    Jackson, A.
    Wu, A. J.
    Gelblum, D.
    Yorke, E. D.
    Simone, C. B., II
    Gomez, D. R.
    Rimner, A.
    Deasy, J. O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E114 - E114
  • [6] Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
    Gao, Robert W.
    Day, Courtney N.
    Yu, Nathan Y.
    Bush, Aaron
    Amundson, Adam C.
    Prodduturvar, Pranitha
    Majeed, Umair
    Butts, Emily
    Oliver, Thomas
    Schwecke, Anna J.
    Moffett, Jenesse N.
    Routman, David M.
    Breen, William G.
    Potter, Ashley L.
    Rivera-Concepcion, Joel
    Hoppe, Bradford S.
    Schild, Steven E.
    Sio, Terence T.
    Lou, Yanyan
    Ernani, Vinicius
    Ko, Stephen
    Olivier, Kenneth R.
    Merrell, Kenneth W.
    Garces, Yolanda, I
    Manochakian, Rami
    Harmsen, William S.
    Leventakos, Konstantinos
    Owen, Dawn
    [J]. LUNG CANCER, 2022, 170 : 58 - 64
  • [7] Radiation pneumonitis after definitive chemoradiation and durvalumab for non-small cell lung cancer
    Voong, Khinh Ranh
    Naidoo, Jarushka
    [J]. LUNG CANCER, 2020, 150 : 249 - 251
  • [8] Durvalumab with Concurrent Definitive Radiation Therapy (DART) for Locally-Advanced Non-Small Cell Lung Cancer - A Phase II Study
    Rimner, A.
    Offin, M.
    Shaverdian, N.
    McKnight, D.
    Li, H.
    Mccune, M.
    Patson, B.
    Kotecha, R.
    Gomez, D. R.
    Chaft, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E929 - E929
  • [9] Efficiency Effectiveness Gap of Durvalumab in Locally Advanced Non-Small Cell Lung Cancer
    Waninger, J. J.
    Bryant, A. K.
    Sankar, K.
    Ramnath, N.
    Green, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E395 - E396
  • [10] Prognostic factors in locally advanced non-small cell lung cancer
    Hadidene, Y.
    Kamoun, H.
    Rejeb, H.
    Greb, D.
    Akrout, I.
    Fkih, L.
    Smadhi, H.
    Megdiche, M. L.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345